Linagliptin for the treatment of type 2 diabetes (pharmacokinetic evaluation)

ISSN： 1742-5255

Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.7, Iss.12, 2011-12, pp. : 1561-1576

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Linagliptin for the treatment of type 2 diabetes

By Del Prato Stefano

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 17, 2011-12 ,pp. : 2759-2762

Informa Healthcare

Access to resources Recommend Favorite

Linagliptin: In Type 2 Diabetes Mellitus

By Scott Lesley J.

Drugs, Vol. 71, Iss. 5, 2011-03 ,pp. : 611-624

Adis International

Access to resources Recommend Favorite

Transmucosal Delivery of Linagliptin for the Treatment of Type- 2 Diabetes Mellitus by Ultra-Thin Nanofibers

Current Drug Delivery, Vol. 12, Iss. 3, 2015-06 ,pp. : 323-332

Bentham Science Publishers

Access to resources Recommend Favorite

Linagliptin: A Review of its Use in the Management of Type 2 Diabetes Mellitus

By Deeks Emma D.

Drugs, Vol. 72, Iss. 13, 2012-09 ,pp. : 1793-1824

Adis International

Access to resources Recommend Favorite

Linagliptin: a guide to its use in type 2 diabetes mellitus

By Scott Lesley J. Lyseng-Williamson Katherine A.

Drugs & Therapy Perspectives, Vol. 28, Iss. 5, 2012-05 ,pp. : 1-5

Adis International

Access to resources Recommend Favorite